Brief: Diacarta Receives U.S. FDA Emergency Use Authorization For Its Monkeypox Test Kit
Jan 12 (Reuters) - HH&L Acquisition Co HHLA.N :
* DIACARTA RECEIVES U.S. FDA EMERGENCY USE AUTHORIZATION FOR
ITS
MONKEYPOX TEST KIT
Source text for Eikon: ID:nGNX3dPkd8
Further company coverage: HHLA.N
((reuters.briefs@thomsonreuters.com;))
Recent news on HH&L Acquisition Co
See all newsBrief: Hh&L Acquisition Co says It Will Redeem All Of Its Outstanding Ordinary Shares That Were Included In Units Issued In Its IPO
Brief: DiaCarta Announces The Termination Of Business Combination Agreement With HH&L Acquisition Co
Brief: Hh&L Acquisition Co Says On June 26, Hh&L Sent Diacarta Ltd., Termination Notice That Hh&L Had Terminated Business Combination Agreement
HHLA calls for final approval of China's Cosco investment in Hamburg port (updated)
Germany's HHLA expects quick feedback from Econ Ministry on Cosco acquisition